Evidence map›Paper›PMID 27409165›Full record

ArticleOncotarget2016

Nuclear IKKα mediates microRNA-7/-103/107/21 inductions to downregulate maspin expression in response to HBx overexpression.

Wen-Shu Chen, Liang-Chih Liu, Chia-Jui Yen, Yun-Ju Chen, Jhen-Yu Chen, Chien-Yi Ho, Shu-Hui Liu, Ching-Chow Chen, Wei-Chien Huang

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Wen-Shu ChenDepartment of Pharmacology, National Taiwan University, Taipei, Taiwan.
Liang-Chih LiuDivision of Breast Surgery, Department of Surgery, China Medical University Hospital, Taichung, Taiwan.
Chia-Jui YenInternal Medicine, National Cheng-Kung University, Tainan, Taiwan.
Yun-Ju ChenDepartment of Medical Research, E-DA Hospital, Kaohsiung, Taiwan.
Jhen-Yu ChenCenter for Molecular Medicine, China Medical University Hospital, Taichung, Taiwan.
Chien-Yi HoDepartment of Family Medicine, China Medical University Hospital, Taichung, Taiwan.
Shu-Hui LiuDepartment of Health Care and Social Work, Yu Da University of Science and Technology, Miaoli, Taiwan.
Ching-Chow ChenDepartment of Pharmacology, National Taiwan University, Taipei, Taiwan.
Wei-Chien HuangCenter for Molecular Medicine, China Medical University Hospital, Taichung, Taiwan.
China Medical University Hospital · TWChina Medical University · TWI-Shou University · TWNational Cheng Kung University · TWNational Taiwan University · TWYu Da University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Maspin is a tumor suppressor that stimulates apoptosis and inhibits metastasis in various cancer types, including hepatocellular carcinoma (HCC). Our previous study has demonstrated that HBx induced microRNA-7, 103, 107, and 21 expressions to suppress maspin expression, leading to metastasis, chemoresistance, and poor prognosis in HCC patients. However, it remains unclear how HBx elicits these microRNA expressions. HBx has been known to induce aberrant activation and nuclear translocation of inhibitor-κB kinase-α (IKKα) to promote HCC progression. In this study, our data further revealed that nuclear IKKα expression was inversely correlated with maspin expression in HBV-associated patients. Nuclear IKKα but not IKKβ reduced maspin protein and mRNA expression, and inhibition of IKKα reverses HBx-mediated maspin downregulation and chemoresistance. In response to HBx overexpression, nuclear IKKα was further demonstrated to induce the gene expressions of microRNA-7, -103, -107, and -21 by directly targeting their promoters, thereby leading to maspin downregulation. These findings indicated nuclear IKKα as a critical regulator for HBx-mediated microRNA induction and maspin suppression, and suggest IKKα as a promising target to improve the therapeutic outcome of HCC patients.

Indexed as

Gene Expression Regulation, NeoplasticApoptosisBiomarkers, TumorCarcinogenesisCarcinoma, HepatocellularCell Line, TumorCell NucleusDisease ProgressionDown-RegulationDrug Resistance, NeoplasmGenes, Tumor SuppressorHEK293 CellsHepatitis B virusHistonesHumansI-kappa B KinaseBiomarkers, TumorCHUK protein, humanhepatitis B virus X proteinHistonesI-kappa B KinaseIKBKB protein, humanMicroRNAsRNA, MessengerSERPIN-B5SerpinsTrans-ActivatorsViral Regulatory and Accessory ProteinsHBxhepatocellular carcinomaIKKαmaspinmicroRNA

Identifiers

PMID27409165
PMCPMC5302916
OpenAlexW2466614528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.